Market research
EOF.AU Ecofibre Limited
AU AUD Healthcare
Latest close
As of 27 Sep 2025
Test a moving-average rule with historical data.
Market facts
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- 1.9
- Dividend yield
- Not available
- Beta
- 1.05
Profile
Instrument facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- AU0000040057
- Market cap
- 8M
- P/E ratio
- Not available
- Analyst target
- 1.9
- Dividend yield
- Not available
- Beta
- 1.05
About
About Ecofibre Limited
Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer textiles, and hemp related food products. Further, it is involved in patient-centered cannabinoid-based drug activities. Ecofibre Limited was incorporated in 2009 and is based in Sydney, Australia.
Research context
Ecofibre Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the EOF.AU discussion.
5 years, 6 months ago
Ecofibre Limited is currently in a long term downtrend where the price is trading 43.3% below its 200 day moving average.
From a valuation standpoint, the stock is 96.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.2.
Ecofibre Limited's total revenue sank by 49.5% to $15M since the same quarter in the previous year.
Its net income has dropped by 178.4% to $-6M since the same quarter in the previous year.
Finally, its free cash flow fell by 4.4% to $-5M since the same quarter in the previous year.
Based on the above factors, Ecofibre Limited gets an overall score of 1/5.